Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Immunome Inc
(NQ:
IMNM
)
15.39
-0.32 (-2.04%)
Streaming Delayed Price
Updated: 11:01 AM EDT, Aug 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Immunome Inc
< Previous
1
2
3
4
5
6
Next >
Immunome Announces Proposed Public Offering of Common Stock
February 13, 2024
From
Immunome, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 06, 2024
Via
Benzinga
Immunome to Acquire AL102, a Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala Pharmaceuticals
February 06, 2024
From
Immunome, Inc.
Via
Business Wire
Immunome Inc. (NASDAQ: IMNM) Leading the Way in Thursday Trading Based on Percentage Gain
June 29, 2023
Via
Investor Brand Network
Exposures
COVID-19
Why Are Immunome Shares Trading Higher Today
June 29, 2023
Immunome Inc (NASDAQ: IMNM) and Morphimmune have announced a merger agreement in
Via
Benzinga
Immunome To Acquire AL102, A Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala Pharmaceuticals
February 06, 2024
AL102 is a small molecule gamma secretase inhibitor with a differentiated clinical profile
From
Ayala Pharmaceuticals
Via
GlobeNewswire
Immunome to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
February 05, 2024
From
Immunome, Inc.
Via
Business Wire
Immunome - Oncology Is Hot
January 10, 2024
Immunome, an oncology biomedical company, has gained 27.48% since a buy signal on December 22.
Via
Talk Markets
Immunome Exclusively Licenses Zentalis ROR1 Antibody-Drug Conjugate and Proprietary Technology Platform
January 08, 2024
From
Immunome, Inc.
Via
Business Wire
Immunome Appoints Phil Roberts as Chief Technical Officer
January 04, 2024
From
Immunome, Inc.
Via
Business Wire
Immunome to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
From
Immunome, Inc.
Via
Business Wire
Immunome Appoints Carol A. Schafer to Board of Directors
January 02, 2024
From
Immunome, Inc.
Via
Business Wire
Immunome to Acquire Antibody-Related Assets and Materials from Atreca
December 26, 2023
From
Immunome, Inc.
Via
Business Wire
Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets and Materials to Immunome
December 26, 2023
From
Atreca, Inc.
Via
GlobeNewswire
Immunome to Present at the Stifel 2023 Healthcare Conference
November 10, 2023
From
Immunome, Inc.
Via
Business Wire
Immunome Reports Third Quarter 2023 Financial Results
November 09, 2023
From
Immunome, Inc.
Via
Business Wire
Immunome Appoints Jean-Jacques Bienaimé to Board of Directors
November 08, 2023
From
Immunome, Inc.
Via
Business Wire
7 Biotech Stocks to Get In Now Before Investors Catch On
October 23, 2023
Biotech stocks are down, but there are hidden gems among the rubble. Get in now before the broader market finds them.
Via
InvestorPlace
Immunome Appoints Bob Lechleider, M.D., as Chief Medical Officer
October 19, 2023
From
Immunome, Inc.
Via
Business Wire
Immunome and Morphimmune Announce Successful Completion of Merger with $125 Million PIPE to Develop Novel Targeted Cancer Therapies
October 03, 2023
From
Immunome, Inc.
Via
Business Wire
Immunome Reports Second Quarter 2023 Financial Results
August 09, 2023
From
Immunome, Inc.
Via
Business Wire
Nasdaq Moves Lower; Acuity Brands Earnings Top Estimates
June 29, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 200 points on Thursday. The Dow traded up 0.68% to 34,081.83 while the NASDAQ fell 0.23% to 13,560.57. The S&P...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
June 29, 2023
Via
Benzinga
Why Franklin Covey Shares Are Trading Higher By 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 29, 2023
Gainers Sigilon Therapeutics, Inc. (NASDAQ: SGTX) shares climbed 523.8% to $24.25 after Eli Lilly agreed to acquire the company for $14.92/share in cash.
Via
Benzinga
IMNM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Immunome, Inc. Is Fair to Shareholders
June 29, 2023
From
Halper Sadeh LLC
Via
Business Wire
Immunome (NASDAQ: IMNM) and Morphimmune Announce Merger to Develop Best-in-Class Targeted Cancer Therapies
June 29, 2023
Via
Spotlight Growth
Exposures
Product Safety
Dow Rises Over 100 Points; US GDP Grows 2% In Q1
June 29, 2023
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.37% to 33,977.04 while the NASDAQ rose...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
June 29, 2023
Via
Benzinga
Immunome and Morphimmune Announce Definitive Merger Agreement and Simultaneous Private Placement Investment of $125 Million to Develop Targeted Cancer Therapies
June 29, 2023
From
Immunome
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 28, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.